Aztreonam Injection 1g (Azactam® / アザクタム注射用1g)

JPY ¥12,700

Japanese Monobactam Antibiotic (Aztreonam 1g). For intravenous or intramuscular treatment of bacterial infections including septicemia, pneumonia, urinary tract infections, and others. 10 vials. Mfd. by Meiji Seika Pharma Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥11,684
10 - 19 12% JPY ¥11,176
20 + 18% JPY ¥10,414
SKU: AZA-1-INJ Category:

Description

Product Overview / 商品概要

Azactam Injection 1g (アザクタム注射用1g)
Generic: Aztreonam / アズトレオナム
Therapeutic Category: Monobactam Antibiotic / モノバクタム系抗生物質製剤
Manufactured by: Meiji Seika Pharma Co., Ltd. / Meiji Seika ファルマ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Aztreonam 1g (potency) per vial / アズトレオナム1g(力価)
Additives: L-Arginine 0.81g / L-アルギニン0.81g
Appearance: White to off-white lump or powder (lyophilized); reconstituted before use. pH: 4.5–7.0 [1g (potency)/10mL Water for Injection JP]; Osmotic pressure ratio (vs. saline): approx. 1.6 [1g (potency)/10mL Water for Injection JP]
外観: 白色~黄白色の塊又は粉末(凍結乾燥品)、用時溶解して用いる注射剤。pH: 4.5~7.0[1g(力価)/10mL日本薬局方注射用水]、浸透圧比(生理食塩液対比): 約1.6[1g(力価)/10mL日本薬局方注射用水]

Indications / 効能効果

EN: Susceptible organisms: Neisseria gonorrhoeae, Neisseria meningitidis, Escherichia coli, Citrobacter spp., Klebsiella spp., Enterobacter spp., Serratia spp., Proteus spp., Morganella morganii, Providencia spp., Haemophilus influenzae, Pseudomonas aeruginosa.
Indications: Septicemia, pneumonia, lung abscess, secondary infections in chronic respiratory disease, cystitis, pyelonephritis, prostatitis (acute and chronic), urethritis, cervicitis, peritonitis, intra-abdominal abscess, cholecystitis, cholangitis, Bartholin gland abscess, intrauterine infection, adnexitis, parametritis, purulent meningitis, keratitis (including corneal ulcer), otitis media, sinusitis.
JA: 〈適応菌種〉本剤に感性の淋菌、髄膜炎菌、大腸菌、シトロバクター属、クレブシエラ属、エンテロバクター属、セラチア属、プロテウス属、モルガネラ・モルガニー、プロビデンシア属、インフルエンザ菌、緑膿菌
〈適応症〉敗血症、肺炎、肺膿瘍、慢性呼吸器病変の二次感染、膀胱炎、腎盂腎炎、前立腺炎(急性症、慢性症)、尿道炎、子宮頸管炎、腹膜炎、腹腔内膿瘍、胆囊炎、胆管炎、バルトリン腺炎、子宮内感染、子宮付属器炎、子宮旁結合織炎、化膿性髄膜炎、角膜炎(角膜潰瘍を含む)、中耳炎、副鼻腔炎

Dosage and Administration / 用法用量

EN: Adults: 1–2g (potency) per day in 2 divided doses by intravenous injection, intravenous infusion, or intramuscular injection. For gonococcal infections and cervicitis, 1–2g (potency) once daily by intramuscular or intravenous injection.
Children: 40–80mg (potency)/kg/day in 2–4 divided doses by intravenous injection or intravenous infusion.
For refractory or severe infections, the dose may be increased to up to 4g (potency)/day in adults (in 2–4 divided doses) and up to 150mg (potency)/kg/day in children (in 3–4 divided doses).
Premature infants and neonates: 20mg (potency)/kg per dose, twice daily for the first 3 days of life, then 2–3 times daily from day 4 onward, by intravenous injection or intravenous infusion.
JA: 通常、成人には、1日1~2g(力価)を2回に分けて静脈内注射、点滴静注又は筋肉内注射する。ただし、通常、淋菌感染症及び子宮頸管炎には、1日1回1~2g(力価)を筋肉内注射又は静脈内注射する。
通常、小児には、1日40~80mg(力価)/kgを2~4回に分けて静脈内注射又は点滴静注する。
なお、年齢、症状に応じて適宜増減するが、難治性又は重症感染症には、成人では1日量4g(力価)まで増量し2~4回に分けて投与し、小児では1日量150mg(力価)/kgまで増量し3~4回に分けて投与する。
通常、未熟児、新生児には、1回20mg(力価)/kgを生後3日までは1日2回、4日以降は1日2~3回静脈内注射又は点滴静注する。

Contraindications / 禁忌

EN: Patients with a history of shock due to any component of this product.
JA: 本剤の成分によるショックの既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 16200MZY00335000
Sales Started: March 1987 / 1987年3月
Classification Code: 876122
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 10 vials / 10バイアル
Other Available Packages (by special order): 10 vials

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Aztreonam Injection 1g (Azactam® / アザクタム注射用1g)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Aztreonam Injection 1g (Azactam®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.